The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis
NCT00045760
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Sepsis
Interventions
DRUG:
Drotrecogin alfa (activated)
Sponsor
Eli Lilly and Company